drugset / Trial / NCT01538940

Immunogenicity of Influenza Vaccines in HIV-infected Persons in Thailand

NCT01538940 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

This study will assess the efficacy of a new intradermal formulation of the trivalent inactivated influenza vaccine compared to the standard intramuscular vaccine in HIV-infected men who have sex with men in Bangkok, Thailand. Relative efficacy of the two different formulations of influenza vaccine will be assessed by comparing immunologic responses to vaccine between the two study arms.

Timeline

Start
2011-11-01
Primary completion
2013-09-09
Completion
2015-10

Outcome

Missed primary endpoint

paper Percentage of seroconversion to all (ID 14% vs IM 15%; P = .8) PMID 26486702 ↗

paper Percentage of seroconversion to all (ID 14% vs IM 15%; P = .8) or at least 1 (ID 69% vs IM 68%; P = .7) PMID 26486702 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Trivalent Inactivated Split Virion Influenza Vaccine Vaccine 15 ug Intravitreal
Subject Trivalent Inactivated Split Virion Influenza Vaccine Vaccine 15 ug Intramuscular

Indications